Latest News
From the Journals
Intraperitoneal chemo missed main endpoint, yet may benefit gastric cancer
Intraperitoneal treatment did show a survival benefit in an analysis adjusted for presence of ascites, in the phase 3 trial of patients with...
Conference Coverage
Pediatric cancers are on the rise
PITTSBURGH – CDC investigators detected a significant increase in pediatric cancers from 2001 through 2014, although the reasons for the rise are...
Conference Coverage
Multiple solid tumors targeted by concept CAR T
PITTSBURGH – Could this CAR T therapy become a viable option against pediatric solid tumors?
Conference Coverage
Upfront NGS testing of metastatic NSCLC saves money, time
NGS at the time of metastatic NSCLC diagnosis could save millions of dollars relative to more conservative testing strategies, and results become...
News
FDA’s Gottlieb floats ideas on Medicare drug coverage
Trump administration officials are eying office-administered drugs in crowded therapeutic categories for the switch from Medicare Part B to...
From the Journals
Is cancer immunotherapy more effective in men than women?
Cancer immunotherapy with checkpoint inhibitors appears to achieve greater mortality reductions in men than in women, regardless of drug or cancer...
From the Journals
Adding bortezomib does not improve MCL outcomes
The addition of bortezomib is a bust in patients with newly diagnosed mantle cell lymphoma.
Commentary
Two more and counting: Suicide in medical trainees
Dr. Michael F. Myers offers context for the latest discussions about physician suicides and calls on the medical community to act now.
News
FDA approves epoetin alfa biosimilar to treat anemia
This is the first product approved as biosimilar to epoetin alfa.
From the Journals
Study: No link between non-Hodgkin lymphoma and Q fever
The study looks at the incidence of non-Hodgkin lymphoma in the Netherlands before, during, and after a Q fever epidemic.
From the Journals
Female cancer researchers receive less funding than male counterparts
In an analysis of cancer research funding awards to U.K. institutions between 2000 and 2013, only 31% were awarded to female primary investigators...